Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone

Completed · Phase 2

Conditions studied: Healthy Volunteers

In brief

This study evaluates the safety of multiple doses of IV MNTX in normal healthy adults.

Key facts

Study ID

NCT01367587

Run by

Bausch Health Americas, Inc.

People needed

12

Starts

2002-04-01

Expected to finish

2002-07-01

Last updated by the study team

2019-11-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must be male or non-pregnant female volunteers
• Must be 18 to 65 yrs of age
• Must have no significant active disease states

You may not qualify if…

• History or current evidence of disease (cardiovascular, respiratory, endocrine, renal, hepatic, hematological, or psychiatric)
• Illicit drug users
• Subjects who received an experimental new drug in the past 30 days
• Subjects with any laboratory findings outside normal limits

Where it is running

• Progenics Pharmaceuticals, Inc. — Tarrytown, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.